cangrelor
SpainDrugs containing this active substance
-
It is used to reduce platelet clumping and thus decrease the probability of blood clots forming. It is prescribed to adults with blocked blood vessels in the heart who require an intervention to remove said blockage.
Form: powder for injectable solution and for perfusion
Active substance Dosage cangrelor 50 mg Manufacturer: Chiesi Farmaceutici S.P.A.